Overview Clinical and experimental studies on focal cortical dysplasia (FCD) were carried out. Materials and methods For the experimental study, an experimental FCD model of rats was developed. Twenty Wistar rats at 0-2 days after birth were used for the study. Kainic acid (KA) solution was injected stereotaxically into medial and lateral sites of the sensori-motor cortex. Bipolar electrodes were inserted in five rats. Their behavior and electroencephalogram (EEG) were recorded using a digitalvideo-EEG monitoring system. After observation periods of 1, 2, and 6 months, rats were perfused for pathological study. FCD was observed adjacent to the site of KA injection in all rats more than 1 month after the injection.
Introduction
Cases of intractable epilepsy have been aggressively treated in recent years by surgical therapies, including focus resection. Moreover, due to recent developments in imaging techniques, it has been revealed that various types of cerebral dysplasia, such as focal cortical dysplasia (FCD) and dysembryoplastic neuroepithelial tumor, are causes of intractable epilepsy in children. Such lesions have shown abnormal neuroglial maturation and differentiation, and it has been shown that there is a close relationship between these dysplastic lesions and epileptogenecity. In epileptic focus resections, we have tried to precisely identify the epileptic focus by using intraoperative electrocorticography (ECoG) and to perform complete resection, but we have often observed epileptiform discharges also in perilesional areas such as the site of FCD. We have carried out pathological studies on epileptic foci. In the present study, we carried out neuroradiological, electrophysiological, and pathological examinations using specimens of resected epileptic foci and an FCD model that we developed in neonatal rats. In this paper, we will discuss about the possible mechanism of epileptogenicity of the focal cortical dysplasia.
Materials and methods

Study in experimental focal cortical dysplasia model of rats
Twenty Wistar rats at 0-2 days after birth were used for the study. Kainic acid (KA) solution was injected stereotaxically into the lateral sites on the sensori-motor cortex. Bipolar electrodes were inserted in five rats 60 days after KA injection. Their behavior and electroencephalogram (EEG) were recorded using a digital-video-EEG monitoring system. After observation periods of 1, 2, and 6 months, rats were perfused for pathological and autoradiographical studies. Immunohistochemical staining for GABA-A and GABA-B receptors and for N-methyl-D-aspartate (NMDA)-R1 and NMDA-R2 was performed in addition to conventional hematoxylin-eosin (HE) staining for pathological examination of resected specimens.
Study in FCD clinical cases
Fifteen cases of FCD with intractable epilepsy were analyzed. The 15 patients included seven males and eight females with ages ranging from 0.9 to 18 years (mean age 8.5 years). The duration of disease ranged from 0.6 to 8 years (mean duration 4.6 years). The types of seizures were GS in 12 patients, SPS in 8 patients, CPS in 4 patients, and West syndrome in i patient. The mean follow-up period after surgery was 18 months. Lesions and epileptic foci were examined by high-resolution magnetic resonance imaging (MRI), ictal and/ or interictal single-photon emission computed tomography (SPECT), and conventional EEG, and ECoG and cortical mapping were also performed after insertion of a subdural electrode for cases with lesions in eloquent areas. After the electrophysiological and radiological examinations, lesionectomy and/or resection of the epileptic focus were performed. At surgery, intraoperative ECoG was performed to localize epileptic foci under neuroleptoanalgesia. The resected specimens were subjected to pathological examination, including HE and immunohistochemical staining for GABA-A and -B, NMDA receptors 1 and 2, and glutamate receptors 1 and 2. 
Results
Study in experimental focal cortical dysplasia model of rats
Epileptiform discharges at and around the site of injection were observed by digital video-EEG monitoring in the five Wistar rats in which kainic acid was injected. Sporadic spike discharges were also observed around the site of injection ( Fig. 1, upper right) . However, clinical seizure was not observed during observation period of 6 months. An autoradiogram obtained by using 125 I-iomazenil showed a reduction in uptake at the site of KA injection, suggesting a decrease in GABA-A receptors ( Fig. 1 , lower right). Specimens stained with HE showed very localized focal cortical dysplasia as well as dyslamination and clusters of dysplastic neurons under the cortex, and the severity of dysplasia was diagnosed to be Palmini grade Ia ∼IIa (Fig. 1,  right) . Immunohistochemical staining for GABA-A showed a reduction in staining intensity at and around the site of FCD and faint staining in some clusters of dysplatic neurons (Fig. 2 , upper left). Staining for GABA-B showed staining at and in a large area around the site of FCD (Fig. 2 , upper right). There was almost no staining for NMDA-R1 or NMDA-R2 (Fig. 2, lower) . The results of staining are summarized in Table 1 .
Examination in FCD clinical cases
Lesion sites could be identified in all 15 cases by MRI, in 12 cases (75%) by EEG, and in 9 cases (60%) by SPECT (Fig. 3) . Intraoperative ECoG have been recorded in 14 cases, and sporadic spike discharges occurred in all cases not only at the lesion site but also around the lesion, indicating the presence of seizure-induced zones and irritable zones (Fig. 4) . Lesionectomy plus focus resection was performed in 14 cases (93.3%), and multiple subpial transection was also performed in five of those cases (35.7%) because of incomplete focus resection especially in the eloquent areas. After surgery, ten patients (66.7%) were free of seizure (Engel class I), two patients were Engel class III, and three patients were Engel class IV. A pathological examination of resected specimens stained with HE showed FCD of Palmini type Ia∼IIc in all cases and angiogenesis suggesting vascular abnormality in one case (Figs. 5 and 6 ). Immunohistochemical study showed a decrease in GABA-A receptors and an increase in GABA-B receptors and also showed an increase Table 1 Summary of the results of immunohistochemical study of the rat focal cortical dysplasia model: GABA-A was negative and GABA-B was positive in both the lesion and perilesional area, and NMDA-R1 and R2 were negative in both areas I-IMP ictal-SPECT image (middle) showed accumulation of tracer corresponding to the lesion site, but less accumulation at the same site was seen on a 125 Iiomazenil SPECT image Fig. 4 As the lesion in case 15 was near Wernicke's area, a subdural electrode was inserted and video-EEG monitoring and cortical mapping were performed. An observation of the brain surface at surgery showed a dark-red lesion with small protrusions and slight cloudiness of the arachnoid membrane but no obvious abnormalities in the perilesional areas (upper left). ECoG at the time of seizure is shown in the upper right, and cortical mapping findings are shown in the lower images. A seizure onset zone, seizure-induced zone and irritable zone were present in perilesional areas, and they overlay with Wernicke's area. Lesionectomy and as much focus resection as possible were performed in this patient. However, the epileptiform discharges did not disappear, and multiple subpial transection was also performed. The patient has been free of seizure (Engel class I) since surgery in glutamate-2 receptors but no or only a slight increase in NMDA receptors (Fig. 6) . The results of immunohistochemical study, which are summarized in Table 2 , showed a decrease in GABA-A staining and positive GABA-B staining in both the lesions and perilesional areas. Moreover, NMDA-R1/-R2 staining and glutamate R1 staining were negative and glutamate R2 staining was positive.
Discussion
Various methods have been used to make FCD models [4] [5] [6] 10] . We have made various epilepsy models using injection of KA [12] [13] [14] 16 ]. In the model used in the present study, KA was injected stereotaxically in newborn rats, and the reproducibility of focal cortical dysplasia was and an ictal SPECT image (right). In the lesion, a decrease in blood flow was seen in the seizure interval stage and an increase in blood flow was seen in the paroxysmal period Fig. 6 Case 4. HE staining of an epileptic focus resected specimen is shown in the upper left image. Angiogenesis can be clearly seen in a part of the FCD site. In the lower left image, reduced staining intensity for GABA-A can be seen in the lesion and perilesional area except for blood vessels. In the lower right image, GABA-B staining can be seen in the lesion and in a large area around the lesion. Glutamate R1 staining (upper right) was mostly negative, whereas glutamate R2 staining (lower right) was positive in a large area therefore high with outer layer of the cortex (I and II). Although epilepsy seizures were not seen by video-EEG monitoring, the fact that frequent intermittent slow spikes and waves and spike bursts in the sensori-motor cortex at the injection site were seen on EEG and the fact that the rats had FCD of Palmini Grade Ia∼IIa [9] indicate that the model is relatively stable and highly reproducible and is therefore a useful model. EEG showed sporadic spike discharges not only in the lesion but also around the lesion in the model. 125 I-iomazenil autoradiography showed a decrease in accumulation of the tracer in the lesion, suggesting a decrease in GABA-A receptors. On the other hand, results of immunohistochemical staining showed reduction in GABA-A staining at the site of FCD and in normal brain tissue around the FCD site, but GABA-B staining was positive in both the lesion and perilesional areas. NMDA staining was negative. The results of our electrophysiological and pathological studies taken together with the results of a study indicating that GABA-A is involved in suppression of seizures and that GABA-B is involved in promotion of seizures [15] suggest that there is epileptogenecity not only in FCD but also in the area around the lesion.
Results of electrophysiological study in the clinical FCD cases similarly showed the existence of seizure onset zones, seizure-induced zones, and irritable zones not only in the lesion but also around the lesion. A pathological study showed a decrease in GABA-A and an increase in GABA-B as were seen in the rat model. NMDA was almost negative, as was glutamate R1. However, glutamate R2 was positive in all cases. There have been a few recent reports on the use of pathological study to identify epileptogenecity in cases of intractable epilepsy accompanying dysplasia such as FCD. Spreafico et al. [11] carried out immunohistochemical studies on FCD resected specimens and reported that an increase in excitatory neurons and a decrease in GABAergic interneurons were involved in epileptogenecity. Benardete and Kriegstein [2] observed a dramatic increase in epileptiform discharge when GABA-A receptors were blocked in a CD model made by administration of BCNU to pregnant rats, and they proposed that GABA is involved in epileptogenecity. Mikuni et al. [7] and Najm et al. [8] also carried out immunohistochemical studies on FCD resected specimens and reported that NMDA-R1 and NMDA-R2A/B are involved in epileptogenecity. Aronica et al. [1] examined metabotropic glutamate receptor subtypes (mGluRs) in FCD resected specimens and reported that group ImGluRs are involved in epileptogenecity. Hagemann et al. [3] produced freeze lesions in rats which mimic human polymicrogyria and performed immunohistochemical studies on NMDA, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate, and KA receptors. They reported the lack of gross and/or widespread alterations of glutamate-receptor subunit distribution in the surroundings of focal cortical dysplasia and suggested the presence of another or additional mechanisms underlying the increased excitatory neurotransmitter binding and excitability in cortical malformations.
The results of our studies in the experimental model and clinical cases suggest the involvement of GABA receptors in epileptogenecity. However, further study is needed in immunohistochemical study using other antibodies for various receptors. Further study using imaging techniques other than autoradiography and SPECT, such as positron emission tomography, is also needed when these tools become of higher resolution level.
Postoperative control of epilepsy in the clinical cases was good: ten patients (66.7%) were free of seizure (Engel class I), two patients were Engel class III, and three patients were Engel class IV. The outcome was better in patients in whom sufficient resection of the focus including the perilesional area was performed. This indicates the importance of sufficient focus resection after precise identification of the epileptic focus by preoperative and intraoperative examinations with neuroradiological and electrophysiological examinations.
Conclusion
Electrophysiological and pathological examinations of the FCD model in rats and clinical cases of FCD revealed the presence of epileptogenecity not only in the lesion but also in the perilesional area. These findings were supported by the results of surgery: postoperative control of epilepsy was very good in patients in whom sufficient focus resection was performed in addition to lesionectomy. Precise identification of the epileptic focus by preoperative and intraoperative electrophysiological examinations is therefore important for a good outcome. Table 2 Summary of results of immunohistochemical study in FCD clinical cases. GABA-A was negative and GABA-B was positive in both the lesion and perilesional area in all cases. NMDA-1/-R2 and glutamate R1 were negative and glutamate R2 was positive in all cases Area GABA-A GABAB-B NMDA-1 NMDA-2 Glu-R1 Glu-R2
